Toggle navigation
Home
Menu
Phenotypes
Genotypes
Strains
Panels, Populations
QTL Archive
Protocols
Contributors
Phenotyping procedures
Behavior tests
Drug and diet studies
Pathogen and challenge studies
Ontologies
Aging studies
Molecular studies
Replicability analysis
Multi-measure study designs
What's new
Submit data
Downloads
MPD data API
Data changelog
Tools demo
About
MyMPD
My Collection
Sign In / Register
Search
Examples
Phenotype measures directly associated with
ontology
term
MP:0006387 'abnormal T cell number'
List studies
MGI
Broaden
Navigate ontologies
This list only includes measures mapped to MP:0006387 directly. Measures mapped to its
ontology descendants
are not included. Alternatively, you can show measures mapped to
MP:0006387 AND its descendants
.
MP:0004972 abnormal regulatory T cell number
MP:0008038 abnormal NK T cell number
MP:0008073 abnormal CD4-positive, alpha beta T cell number
MP:0008077 abnormal CD8-positive, alpha-beta T cell number
MP:0010849 abnormal effector memory CD8-positive, alpha-beta T cell number
MP:0012769 abnormal CD4-positive, alpha-beta memory T cell number
MP:0012770 abnormal effector memory CD4-positive, alpha-beta T cell number
MP:0012772 abnormal central memory CD8-positive, alpha-beta T cell number
MP:0012773 abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number
This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.
Filter Table Results
Data set
Clear All
Donahue5
(1)
Donahue6
(1)
Graham3
(3)
Hackstein1
(2)
Lesage1
(1)
Wiltshire4
(4)
Procedure / Protocol
Clear All
immune cell quant...
(12)
Treatment
Clear All
(none)
(8)
BEZ235
(1)
doxorubicin
(1)
idarubicin
(1)
selumetinib
(1)
Panel
Clear All
B6.A consomic w/par
(1)
B6.PWD consomic w...
(1)
CC RIX
(3)
CC w/par
(1)
inbred
(2)
inbred w/CC7
(4)
Sex
Clear All
both
(3)
m
(9)
Select table page:
5
10
25
100
all
Help / filtering
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
Donahue5:9
Donahue5
immune cell quantification
(none)
T cells (percentage of viable WBC) [%]
pct_T_cells
41409
B6.A consomic w/par
22
both
7wks
N=8
2011
Donahue6:9
Donahue6
immune cell quantification
(none)
T cells (percentage of viable WBC) [%]
pct_T_cells
41509
B6.PWD consomic w/par
28
both
7wks
N=8
2011
Graham3:21
Graham3
immune cell quantification
(none)
percentage of splenic lymphocytes that are CD3+ T cells (memory precursor panel) [%]
mp_CD3_pos
113812
CC RIX
92
m
8-10wks
N=4
2021
Graham3:34
Graham3
immune cell quantification
(none)
percentage of splenic lymphocytes that are CD3+ T cells (memory panel) [%]
mem_CD3_pos
113825
CC RIX
68
m
8-10wks
N=3
2021
Graham3:47
Graham3
immune cell quantification
(none)
percentage of splenic lymphocytes that are CD3+ T cells following stimulation with anti-CD3 and anti CD28 [%]
ics_CD3_pos
113838
CC RIX
102
m
8-10wks
N=4
2021
Hackstein1:14
Hackstein1
immune cell quantification
(none)
bronchoalveolar lavage CD3+ T cells (percentage of CD45+ cells) [%]
T_CD3
49114
inbred
5
m
7-11wks
N=9
2012
Hackstein1:21
Hackstein1
immune cell quantification
(none)
bronchoalveolar lavage CD3+ gamma-delta T cells (percentage of CD45+ cells) [%]
T_gd
49121
inbred
5
m
7-11wks
N=9
2012
Lesage1:15
Lesage1
immune cell quantification
(none)
percentage of splenic lymphocytes that are T cells [%]
T_cells
63515
CC w/par
76
both
5-8wks
N=2
2018
Wiltshire4:7
Wiltshire4
immune cell quantification
BEZ235
T cells, percent viability [%]
Tcells_BEZ
52407
dose [µM]: control 0.046 0.137 1.235 11.1 100
inbred w/CC7
34
m
10wks
N=4
2015
Wiltshire4:27
Wiltshire4
immune cell quantification
doxorubicin
T cells, percent viability [%]
Tcells_Dox
52427
dose [µM]: control 0.046 0.137 1.235 11.1 100
inbred w/CC7
35
m
10wks
N=4
2015
Wiltshire4:47
Wiltshire4
immune cell quantification
idarubicin
T cells, percent viability [%]
Tcells_Ida
52447
dose [µM]: control 0.046 0.137 1.235 11.1 100
inbred w/CC7
35
m
10wks
N=4
2015
Wiltshire4:67
Wiltshire4
immune cell quantification
selumetinib
T cells, percent viability [%]
Tcells_Sel
52467
dose [µM]: control 0.046 0.137 1.235 11.1 100
inbred w/CC7
34
m
10wks
N=4
2015
All boxes
To see
more rows
use the paging control at top.
Work with selected measures
Or, add these measures to your collection.
no folder
put them in new folder
FUNDING
CITING MPD
UNITS
CHANGE LOG
CONTACT
HELP | FEEDBACK
TERMS OF USE | PRIVACY POLICY
RESEARCH RESOURCES
MOUSE GENOME INFORMATICS
© 2001-2024 THE JACKSON LABORATORY